Selective Laser Trabeculoplasty (SLT) has become a primary treatment option for managing open-angle glaucoma and ocular hypertension. This procedure uses a highly focused cold laser to target specific cells in the eye’s drainage system without causing permanent damage to the surrounding tissue. By stimulating the body’s natural healing response, the laser improves the outflow of fluid from the eye, which effectively lowers intraocular pressure. For many patients, SLT offers a reliable and long-lasting alternative to daily eye drops, making it a cornerstone of modern ophthalmic care in the UK.
What We’ll Discuss in This Article
- The mechanism of action behind SLT and how it lowers eye pressure.
- The success rate of SLT in patients with newly diagnosed open-angle glaucoma.
- How the effectiveness of SLT compares to traditional medicated eye drops.
- The duration of the treatment’s effect and the possibility of repeat procedures.
- Factors that influence how well an individual responds to laser therapy.
- The safety profile and common post-operative outcomes for patients.
- Current clinical guidelines regarding SLT as a first-line treatment.
The Mechanism of Selective Laser Trabeculoplasty
SLT is effective because it targets the trabecular meshwork, which is the natural drainage site located at the front of the eye. In open-angle glaucoma, this meshwork becomes less efficient at allowing aqueous humor to exit, leading to a buildup of pressure. The “selective” nature of the laser means it only affects the pigmented cells within the meshwork, leaving the non-pigmented structural cells intact. This triggers a biological remodeling process that opens the drainage channels and restores a healthier flow of fluid.
Unlike older laser techniques that used high heat and caused scarring, SLT uses short, low-energy pulses. This gentle approach is why the procedure is often referred to as “cold laser” therapy. Because it does not cause thermal damage or structural changes to the eye’s anatomy, it is considered a very safe way to achieve significant pressure reduction. The improvement in drainage usually manifests over a period of four to twelve weeks following the procedure.
Success Rates and Pressure Reduction
Clinical research has consistently shown that SLT is effective in lowering intraocular pressure by approximately 20% to 30% in the majority of patients. This level of reduction is often sufficient to reach a safe target pressure that protects the optic nerve from further damage. About 75% to 80% of people who undergo SLT respond positively to the treatment, experiencing a meaningful drop in their eye pressure.
The effectiveness can vary depending on the individual’s baseline pressure. Generally, patients with higher initial pressure tend to see a more significant numerical drop after the laser. It is important to note that while SLT is highly effective for most, a small percentage of patients may not respond as expected. In these instances, clinicians may combine the laser with a low dose of eye drops or consider alternative surgical options to ensure the glaucoma remains well-controlled.
SLT Versus Medicated Eye Drops
For many years, eye drops were the standard first-line treatment for glaucoma, but recent evidence has shifted the clinical landscape. Large-scale studies, such as the LiGHT trial, have demonstrated that SLT is just as effective as eye drops for initial treatment. In many cases, patients who receive SLT as their first treatment are more likely to stay within their target pressure range over a three-year period compared to those using drops.
One of the main reasons SLT is considered more effective in a “real-world” setting is that it removes the issue of patient adherence. Eye drops only work if they are used correctly and consistently every single day. Many patients struggle with the routine, leading to dangerous fluctuations in eye pressure. SLT provides “round-the-clock” pressure control that does not rely on the patient remembering to apply medication, which significantly reduces the risk of silent vision loss.
Duration of Treatment and Repeatability
The pressure-lowering effect of SLT is not always permanent, but it is typically long-lasting. On average, the benefits of a single laser session last between three to five years. For some patients, the effect may last even longer. As the eye continues to age, the drainage meshwork may gradually become less efficient again, causing the pressure to slowly rise.
One of the most significant advantages of SLT over other laser treatments is its repeatability. Because the procedure does not cause scarring or permanent tissue damage, it can be safely repeated if the initial effect begins to wear off. This allows many patients to manage their glaucoma for a decade or more without ever needing to rely on daily eye drops, provided they attend regular follow-up appointments to monitor their pressure levels.
SLT as a First-Line Treatment Option
Based on robust clinical evidence, current NICE guidance on glaucoma now recommends that SLT be offered as the first treatment option for people with newly diagnosed primary open-angle glaucoma or ocular hypertension. This recommendation is based on both the clinical effectiveness of the laser and its cost-effectiveness for the healthcare system. It provides a way to stabilise the condition early, potentially avoiding the side effects and complications associated with long-term medication use.
Choosing SLT at the start of the treatment journey can prevent the redness, dryness, and eyelid changes that often occur with years of eye drop use. It also simplifies life for the patient, as they do not have to carry medication or worry about administration while traveling or at work. Most NHS eye departments now offer SLT as a standard part of their glaucoma pathway for suitable candidates.
Safety Profile and What to Expect
The safety of SLT is one of the reasons it is so widely recommended. The procedure is performed in an outpatient clinic and takes only about five to ten minutes. After the eye is numbed with drops, a special lens is placed on the eye to guide the laser. Most patients describe the sensation as a series of small “clicks” or flashes of light, and it is generally painless.
| Aspect of SLT | Clinical Expectation |
| Procedure Time | 5 to 10 minutes per eye |
| Recovery Period | 24 to 48 hours for mild blurriness |
| Success Rate | ~80% of patients respond |
| Average Duration | 3 to 5 years per treatment |
| Repeatability | Can be performed multiple times |
After the procedure, some patients may experience mild light sensitivity or a slight ache in the eye for a day or two, which can usually be managed with standard over-the-counter pain relief. A short course of anti-inflammatory drops is sometimes prescribed to help the eye settle. According to the NHS page on glaucoma treatment, while laser is very safe, regular check-ups remain essential to ensure the pressure remains at the required level over time.
Conclusion
Selective Laser Trabeculoplasty (SLT) is a highly effective, safe, and repeatable treatment for open-angle glaucoma. It has proven to be as successful as eye drops in lowering intraocular pressure while offering the added benefit of consistent, 24-hour control without the need for daily medication. As a result, it is now the recommended first-line treatment in the UK for many patients. If you experience severe, sudden, or worsening symptoms, such as sudden vision loss or intense eye pain, call 999 immediately.
What is the primary purpose of Selective Laser Trabeculoplasty (SLT)?
SLT is designed to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension by improving the eye’s natural fluid drainage. It achieves this by stimulating a biological healing response in the drainage pathways without causing thermal or structural damage to the surrounding tissue.
Does SLT hurt during or after the procedure?
The procedure is generally painless because local anaesthetic drops are used to numb the eye beforehand. Most patients only feel a mild pressure or see brief flashes of light, and any minor aching or light sensitivity afterward typically resolves within a day or two.
Can I stop taking my eye drops immediately after having SLT?
You should not stop taking prescribed eye drops unless your ophthalmologist or healthcare professional explicitly instructs you to do so. It often takes several weeks for the full pressure-lowering effect of the laser to develop, and your doctor will need to monitor your pressure before adjusting any medications.
What happens if the effects of the SLT wear off over time?
The pressure-lowering benefits of SLT can gradually diminish after a few years as the drainage meshwork ages. However, because the procedure does not scar the tissue, it is fully repeatable, allowing your specialist to perform another session if necessary.
Is SLT suitable for every type of glaucoma?
SLT is primarily effective for open-angle glaucoma and ocular hypertension where the drainage angle is visible and unobstructed. It is generally not used for closed-angle glaucoma, which requires entirely different clinical interventions to manage the fluid blockage.
Authority snapshot
This article examines the clinical effectiveness of Selective Laser Trabeculoplasty (SLT) in the management of open-angle glaucoma. The content has been developed and reviewed by the medical content team to ensure it provides accurate and up-to-date patient education. All information is strictly aligned with NHS and NICE protocols, reflecting current UK clinical practice and guidelines for the first-line treatment of glaucoma.
